CroíValve raises €3.2M in oversubscribed funding round
CroíValve, a medtech start-up providing a safe and effective treatment for tricuspid regurgitation, today announces that it has secured €3.2 million in an oversubscribed seed financing round. The round was led by the HBAN (Halo Business Angel Network) MedTech and Irrus Syndicates, alongside Atlantic Bridge University Fund, Enterprise Ireland, SOSV and a group of cardiologists who see the treatment’s transformative potential. The funding will support the continued development of CroíValve’s innovative technology.
Read Full Article from HBAN
Date: March 27, 2019
Provided By: https://www.hban.org/_shared/news/RSSNewsPage.aspx?Id=9